7T MRI scans for migraine, visual snow, and epilepsy
Official title: High-field MR Imaging in Migraine, Visual Snow and Epilepsy
Run by University of Zurich · NCT05524493 · Data updated 2026-11-12
This project will use high-field 7T MRI to try to find microstructural and network differences in people with migraine, visual snow, or drug‑resistant epilepsy and in healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 2 sites (Zurich and 1 other locations) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | October 8, 2025 |
| Trial ID | NCT05524493 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults able to give informed consent who have migraine (≥2 attacks/month), drug‑resistant epilepsy by ILAE criteria, or visual snow syndrome, with stable prophylactic medication for at least two months, and healthy volunteers without migraine or epilepsy for the control group.
✕Probably not a fit
Patients who are pregnant or breastfeeding, planning pregnancy during the study, recently treated with Botox for migraine (<4 months), unable to undergo 7T MRI (e.g., incompatible implants or severe claustrophobia), or seeking immediate therapeutic interventions are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will recruit people with migraine, visual snow syndrome, drug‑resistant epilepsy, and healthy controls and scan them on a clinical 7T Terra Siemens MRI. Multimodal imaging will include structural, quantitative, diffusion, functional MRI and MR spectroscopy to characterize microstructure and network changes. Participants will also complete clinical assessments and questionnaires (including the HARDSHIP migraine questionnaire) and provide medication history. The goal is to compare disease‑specific brain regions and networks across groups to better understand shared and distinct pathophysiology.
Why it matters
Potential benefit: If successful, the findings could identify imaging signatures that help improve diagnosis and guide future targeted therapies for these disorders.
How similar studies have gone: Previous high‑field and multimodal MRI studies have shown promising microstructural and functional differences in migraine and epilepsy, but combining migraine, visual snow and drug‑resistant epilepsy in a single 7T protocol is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: * Patient must be able to read and sign the informed consent form * Stable prophylactic medication for 2 months prior to MRI * At leat one of the two criteria applies: * Patients diagnosed with migraine (with or without aura, episodic or chronic). Diagnosis is ensured by clinical interview (at least 8 weeks prior to MRI). Also, patients complete a migraine questionnaire (HARDSHIP) (at least 8 weeks before MRI). Migraine frequency ≥ 2 migraine attacks/month. * Patients with drug resistent epilepsy accroding to ILAE crtieria * Patients with diagnoses of Visual snow syndrome Healthy participants; * No migraine (validated by questionnaire) or epilepsy * Participants must be able to read and sign the informed consent form Exclusion Criteria: * Treatment of migraine disease with Botox within \< 4 months before baseline and during the study period * Pregnant or breastfeeding women * Intention during the course of the trial to become pregnant * Women with bilateral ovariectomy, with or without hysterectomy, and postmenopausal women (\>2 years of age) are not considered childbearing. * Other clinically significant comorbidities (e.g., renal insufficiency, hepatic dysfunction, cardiovascular disease, etc.), * Known or suspected noncompliance with the protocol, drug or alcohol abuse, * Patient's inability to follow trial procedures, e.g., due to language problems, mental illness, dementia, etc., * Prior participation in the clinical trial * Enrolment of the investigator, his/ her family members, employees and other dependent persons of the test personnel * Metallic objects in the body (e.g., splinters, MR incompatible implants). * Pacemaker * Claustrophobia * Obesity (body mass index \> 35 kg/m2)
Where it's running
-
Klinik Lengg
Zurich, Switzerland Recruiting -
University Hospital Zurich
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Patrick Freund, Prof. Dr. med. Dr. rer. nat. — University of Zurich
- Study coordinator: Lynn Farner, MSc
- Email: lynn.farner@balgrist.ch
- Phone: +41 44 510 72 08
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain function and visual adaptation in people with and without Visual Snow
This project will test whether brain activity and responses to visual stimuli differ between adults with Visual Snow Syndrome, adults with migraine, and healthy adults.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.